Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D

被引:29
|
作者
Tsukamoto, Kentaro [2 ]
Kozai, Yuiko [1 ]
Ihara, Hideshi [3 ]
Kohda, Tomoko [1 ]
Mukamoto, Masafumi [1 ]
Tsuji, Takao [2 ]
Kozaki, Shunji [1 ]
机构
[1] Osaka Prefecture Univ, Dept Vet Sci, Grad Sch Life & Environm Sci, Naka Ku, Osaka 5998531, Japan
[2] Fujita Hlth Univ, Dept Microbiol, Sch Med, Aichi 4701192, Japan
[3] Osaka Prefecture Univ, Dept Biol Sci, Grad Sch Sci, Naka Ku, Osaka 5998531, Japan
关键词
D O I
10.1016/j.micpath.2007.12.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Botulinum neurotoxin (BoNT) binds to presynaptic neuronal cells and blocks neurotransmitter release. The carboxyl-terminal half of the heavy chain (H-C) of the neurotoxin recognizes its specific receptor oil the plasma membrane. We have previously demonstrated that BoNT/C binds to gangliosides GD1b and GT1b under physiological conditions, while BoNT/D interacts with phosphatidylethanolamine (PE). Here we report that the recognition sites for gangliosides and PE are present in the carboxyl-terminal domain of H-C. Chimeric mutants and site-directed mutants of BoNT/C-H-C. and BoNT/D-H-C were generated and their binding activities evaluated. The chimeric H-C that consisted of the amino-terminal half of BoNT/D-H-C and the carboxyl-terminal half of BoNT/C-H-C possessed activity similar to the authentic BoNT/C-H-C. suggesting that the carboxyl-terminal region of H-C is involved in the receptor recognition of BoNT/C. Moreover, analysis using site-directed mutants indicated that the peptide motif (WY)-Y-1257...G(1270)...H-1282 plays,in important role in the interaction between BoNT/C and gangliosides. In contrast, we revealed that two lysine residues of BoNT/D-H-C are involved in the formation of the critical binding site for receptor binding. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:484 / 493
页数:10
相关论文
共 50 条
  • [31] Structural and mutational analyses of the receptor binding domain of botulinum D/C mosaic neurotoxin: Insight into the ganglioside binding mechanism
    Nuemket, Nipawan
    Tanaka, Yoshikazu
    Tsukamoto, Kentaro
    Tsuji, Takao
    Nakamura, Keiji
    Kozaki, Shunji
    Yao, Min
    Tanaka, Isao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 411 (02) : 433 - 439
  • [32] The C-Terminal Heavy-Chain Domain of Botulinum Neurotoxin A Is Not the Only Site That Binds Neurons, as the N-Terminal Heavy-Chain Domain Also Plays a Very Active Role in Toxin-Cell Binding and Interactions
    Ayyar, B. Vijayalakshmi
    Aoki, K. Roger
    Atassi, M. Zouhair
    INFECTION AND IMMUNITY, 2015, 83 (04) : 1465 - 1476
  • [33] Differential contribution of the residues in C-terminal half of the heavy chain of botulinum neurotoxin type B to its binding to the ganglioside GT1b and the synaptotagmin 2/GT1b complex
    Kohda, Tomoko
    Ihara, Hideshi
    Seto, Yukiji
    Tsutsuki, Hiroyasu
    Mukamoto, Masafumi
    Kozaki, Shunji
    MICROBIAL PATHOGENESIS, 2007, 42 (2-3) : 72 - 79
  • [34] Immunogenic and protective potentials of recombinant receptor binding domain and a C-terminal fragment of Clostridium botulinum neurotoxin type E
    Gargari, Seyed Latif Mousavi
    Rasooli, Iraj
    Valipour, Ebrahim
    Basiri, Mohsen
    Nazarian, Shahram
    Amani, Jafar
    Farhadi, Nima
    IRANIAN JOURNAL OF BIOTECHNOLOGY, 2011, 9 (03) : 181 - 187
  • [35] IDENTIFICATION OF LEUKOTRIENE C-4 AND D4 RECEPTOR-BINDING SITES IN GUINEA-PIG LUNG MEMBRANES
    WU, HL
    MONG, S
    HOGABOOM, GK
    CLARK, MA
    CROOKE, ST
    FEDERATION PROCEEDINGS, 1984, 43 (03) : 689 - 689
  • [36] Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H
    Hellwage, J
    Jokiranta, TS
    Friese, MA
    Wolk, TU
    Kampen, E
    Zipfel, PF
    Meri, S
    JOURNAL OF IMMUNOLOGY, 2002, 169 (12): : 6935 - 6944
  • [37] Identification of carboxyl-terminal phosphorylation sites regulating agonist-induced β-arrestin recruitment and internalization of the human sst3 somatostatin receptor
    Fritzwanker, S.
    Lehmann, A.
    Kliewer, A.
    Guenther, T.
    Nagel, F.
    Schulz, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S27 - S27
  • [38] Cloning, high level expression and immunogenicity of 1163-1256 residues of C-terminal heavy chain of C. botulinum neurotoxin type E
    Mansour, Abdoulreza Agheli
    Mousavi, Seyed Latif
    Rasooli, Iraj
    Nazarian, Shahram
    Amani, Jafar
    Farhadi, Nima
    BIOLOGICALS, 2010, 38 (02) : 260 - 264
  • [39] High-level expression, purification, crystallization and preliminary X-ray crystallographic studies of the receptor-binding domain of botulinum neurotoxin serotype D
    Zhang, Yanfeng
    Gao, Xiaoli
    Qin, Ling
    Buchko, Garry W.
    Robinson, Howard
    Varnum, Susan M.
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2010, 66 : 1610 - 1613
  • [40] Easy expression of the C-terminal heavy chain domain of botulinum neurotoxin serotype A as a vaccine candidate using a bi-cistronic baculovirus system
    Villaflores, Oliver B.
    Hsei, Chein-Ming
    Teng, Chao-Yi
    Chen, Ying-Ju
    Wey, Jiunn-Jye
    Tsui, Pei-Yi
    Shyu, Rong-Hwa
    Tung, Kuo-Lun
    Yeh, Jui-Ming
    Chiao, Der-Jiang
    Wu, Tzong-Yuan
    JOURNAL OF VIROLOGICAL METHODS, 2013, 189 (01) : 58 - 64